Kevin Hershberger

Kevin is Lumicell’s Chief Executive Officer and brings over 25 years of global executive management experience in a variety of life science products and manufacturing companies with an extensive range of expertise and leadership responsibilities. He joined Lumicell as the Chief Financial Officer in 2018 and became President and CFO in 2019. Prior to Lumicell, Kevin most recently served as Chief Financial Officer of ReWalk Robotics where he built out the company’s finance function and launched a partnership with Harvard University’s Wyss Institute encompassing a broad licensing and collaboration agreement to develop a Softsuit Exoskeleton. Prior to ReWalk, he held leadership roles with NxStage Medical as the Vice President of Finance, Controller, and Chief Accounting Officer. Kevin also served in a variety of finance leadership roles at Boston Scientific.